TABLE 4.
Levels of IgA1 protease inhibition in cervical mucus from patients with and without gonococcal infection
| Subject group | Visit no.a | Inhibition level, median (range) | Relative inhibition level,b median (range) | No. of patients with positive inhibition titers/n |
|---|---|---|---|---|
| Noninfected | 1 | 0.1c (0.1–70) | 10.5 (0.5–5,454.5) | 9/26 |
| 2 | 0.1 (0.1–25) | 9.3 (0.6–1,707.0) | 3/11 | |
| N. gonorrhoeae | 1 | 0.1 (0.1–24) | 4.6 (0.2–158.6) | 3/17 |
| infected | 2 | 0.1 (0.1–12.6) | 4.9 (0.5–417.2) | 1/11 |
a
Visit 1, at time of treatment; visit 2, 2 weeks after treatment.
b
Ratio of inhibition level to total IgA1 concentration (milligrams per milliliter).
c
Levels below that detectable were assigned a value of 0.1.